Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRDT | Q58F21 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.31 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.31 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.31 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.31 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23983815 | 0.89 | BRDT (0.32) | BRDTNPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL21735958 | 0.89 | PRKDC (0.35) | BRDTNPC1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL23026764 | 0.89 | BRDT (0.31) | BRDT | |
| SCHEMBL21736480 | 0.88 | PIM1 (0.34) | NPC1CYP1A2CYP2C9CYP2C19RAB9A | |
| SCHEMBL21736085 | 0.86 | PIM1 (0.35) | NPC1CYP1A2CYP2C9CYP2C19RAB9A | |
| SCHEMBL21735962 | 0.86 | BRDT (0.32) | BRDT | |
| SCHEMBL21736208 | 0.85 | ALOX5 (0.37) | NPC1CYP1A2CYP2C9CYP2C19RAB9A | |
| SCHEMBL18961971 | 0.85 | NPC1 (0.30) | NPC1CYP1A2CYP2C9CYP2C19RAB9A | |
| SCHEMBL18962067 | 0.85 | CREBBP (0.32) | NPC1CYP1A2CYP2C9CYP2C19RAB9A | |
| SCHEMBL20669826 | 0.85 | PIM1 (0.33) | NPC1CYP1A2CYP2C9CYP2C19RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | LG CHEM, LTD. (KR) | 2022-12-20 | — | — | US | disclosed |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11530225-B2 | Compound and organic light-emitting diode comprising same | CRY1, CRY2, TRPA1 | BRDT 3267/4885NPC1 1021/4885CYP1A2 20/4885 |
| US-20200055865-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DIODE COMPRISING SAME | CRY1, CRY2, TRPA1 | BRDT 3267/4885NPC1 1021/4885CYP1A2 20/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.